COVID-19 Vaccines and Monoclonal Antibodies

Mary Madison, RN, RAC-CT, CDP 
Clinical Consultant – Briggs Healthcare

The subtitle of this website (same title as this blog) is Medicare Part B Payment for COVID-19 Vaccines and Certain Monoclonal Antibodies during the Public Health Emergency.  The website was updated on August 16, 2021.

CMS has released a set of toolkits for providers, states and insurers to help the health care system prepare and assist in swiftly administering these products once they become available.  These resources are designed to increase the number of providers that can administer the products and ensure adequate reimbursement for administration in Medicare, while making it clear to private insurers and Medicaid programs their responsibility to cover these products at no charge to beneficiaries.  This webpage provides the payment allowances and other related information for these products.  For more information, review the COVID-19 provider toolkit.

Below are 3 samples of the wealth of information on this landing page:

The above are just a thumbnail of the information on this website.  Please bookmark and share this information with your billers, physicians and clinicians.